197 related articles for article (PubMed ID: 32600353)
1. Radiogenomics correlation between MR imaging features and mRNA-based subtypes in lower-grade glioma.
Liu Z; Zhang J
BMC Neurol; 2020 Jun; 20(1):259. PubMed ID: 32600353
[TBL] [Abstract][Full Text] [Related]
2. Magnetic Resonance Features of Lower-grade Gliomas in Prediction of the Reverse Phase Protein A.
Wang J; Guo X
J Comput Assist Tomogr; 2021 Mar-Apr 01; 45(2):300-307. PubMed ID: 33512852
[TBL] [Abstract][Full Text] [Related]
3. Lower-Grade Gliomas: Predicting DNA Methylation Subtyping and its Consequences on Survival with MR Features.
Zhang H; Xu L; Zhong Z; Liu Y; Long Y; Zhou S
Acad Radiol; 2021 Jul; 28(7):e199-e208. PubMed ID: 32241714
[TBL] [Abstract][Full Text] [Related]
4. Development of MR-based preoperative nomograms predicting DNA copy number subtype in lower grade gliomas with prognostic implication.
Zhang S; Wu S; Wan Y; Ye Y; Zhang Y; Ma Z; Guo Q; Zhang H; Xu L
Eur Radiol; 2021 Apr; 31(4):2094-2105. PubMed ID: 33025175
[TBL] [Abstract][Full Text] [Related]
5. Conventional MR-based Preoperative Nomograms for Prediction of IDH/1p19q Subtype in Low-Grade Glioma.
Liu Z; Zhang T; Jiang H; Xu W; Zhang J
Acad Radiol; 2019 Aug; 26(8):1062-1070. PubMed ID: 30393056
[TBL] [Abstract][Full Text] [Related]
6. Radiomic Analysis of Contrast-Enhanced MRI Predicts DNA Copy-Number Subtype and Outcome in Lower-Grade Gliomas.
Wan Y; Zhou S; Zhang Y; Deng X; Xu L
Acad Radiol; 2022 Sep; 29(9):e189-e196. PubMed ID: 34916150
[TBL] [Abstract][Full Text] [Related]
7. Advanced imaging parameters improve the prediction of diffuse lower-grade gliomas subtype, IDH mutant with no 1p19q codeletion: added value to the T2/FLAIR mismatch sign.
Lee MK; Park JE; Jo Y; Park SY; Kim SJ; Kim HS
Eur Radiol; 2020 Feb; 30(2):844-854. PubMed ID: 31446467
[TBL] [Abstract][Full Text] [Related]
8. Machine learning and radiomic phenotyping of lower grade gliomas: improving survival prediction.
Choi YS; Ahn SS; Chang JH; Kang SG; Kim EH; Kim SH; Jain R; Lee SK
Eur Radiol; 2020 Jul; 30(7):3834-3842. PubMed ID: 32162004
[TBL] [Abstract][Full Text] [Related]
9. Conventional Magnetic Resonance Features for Predicting 1p19q Codeletion Status of World Health Organization Grade II and III Diffuse Gliomas.
Peng X; Yishuang C; Kaizhou Z; Xiao L; Ma C
J Comput Assist Tomogr; 2019; 43(2):269-276. PubMed ID: 30371623
[TBL] [Abstract][Full Text] [Related]
10. Fusion Radiomics Features from Conventional MRI Predict MGMT Promoter Methylation Status in Lower Grade Gliomas.
Jiang C; Kong Z; Liu S; Feng S; Zhang Y; Zhu R; Chen W; Wang Y; Lyu Y; You H; Zhao D; Wang R; Wang Y; Ma W; Feng F
Eur J Radiol; 2019 Dec; 121():108714. PubMed ID: 31704598
[TBL] [Abstract][Full Text] [Related]
11. Radiogenomics of lower-grade glioma: algorithmically-assessed tumor shape is associated with tumor genomic subtypes and patient outcomes in a multi-institutional study with The Cancer Genome Atlas data.
Mazurowski MA; Clark K; Czarnek NM; Shamsesfandabadi P; Peters KB; Saha A
J Neurooncol; 2017 May; 133(1):27-35. PubMed ID: 28470431
[TBL] [Abstract][Full Text] [Related]
12. Identification and Validation of an Energy Metabolism-Related lncRNA-mRNA Signature for Lower-Grade Glioma.
Zhao J; Wang L; Wei B
Biomed Res Int; 2020; 2020():3708231. PubMed ID: 32802843
[TBL] [Abstract][Full Text] [Related]
13. Development and validation of an MRI-based nomogram for the preoperative prediction of tumor mutational burden in lower-grade gliomas.
Liu ET; Zhou S; Li Y; Zhang S; Ma Z; Guo J; Guo L; Zhang Y; Guo Q; Xu L
Quant Imaging Med Surg; 2022 Mar; 12(3):1684-1697. PubMed ID: 35284257
[TBL] [Abstract][Full Text] [Related]
14. Conventional magnetic resonance imaging-based radiomic signature predicts telomerase reverse transcriptase promoter mutation status in grade II and III gliomas.
Jiang C; Kong Z; Zhang Y; Liu S; Liu Z; Chen W; Liu P; Liu D; Wang Y; Lyu Y; Zhao D; Wang Y; You H; Feng F; Ma W
Neuroradiology; 2020 Jul; 62(7):803-813. PubMed ID: 32239241
[TBL] [Abstract][Full Text] [Related]
15. Predicting Genotype and Survival in Glioma Using Standard Clinical MR Imaging Apparent Diffusion Coefficient Images: A Pilot Study from The Cancer Genome Atlas.
Wu CC; Jain R; Radmanesh A; Poisson LM; Guo WY; Zagzag D; Snuderl M; Placantonakis DG; Golfinos J; Chi AS
AJNR Am J Neuroradiol; 2018 Oct; 39(10):1814-1820. PubMed ID: 30190259
[TBL] [Abstract][Full Text] [Related]
16. Radiomics MRI Phenotyping with Machine Learning to Predict the Grade of Lower-Grade Gliomas: A Study Focused on Nonenhancing Tumors.
Park YW; Choi YS; Ahn SS; Chang JH; Kim SH; Lee SK
Korean J Radiol; 2019 Sep; 20(9):1381-1389. PubMed ID: 31464116
[TBL] [Abstract][Full Text] [Related]
17. 3D-ASL perfusion correlates with VEGF expression and overall survival in glioma patients: Comparison of quantitative perfusion and pathology on accurate spatial location-matched basis.
Pang H; Dang X; Ren Y; Zhuang D; Qiu T; Chen H; Zhang J; Ma N; Li G; Zhang J; Wu J; Feng X
J Magn Reson Imaging; 2019 Jul; 50(1):209-220. PubMed ID: 30652410
[TBL] [Abstract][Full Text] [Related]
18. SHOX2 is a Potent Independent Biomarker to Predict Survival of WHO Grade II-III Diffuse Gliomas.
Zhang YA; Zhou Y; Luo X; Song K; Ma X; Sathe A; Girard L; Xiao G; Gazdar AF
EBioMedicine; 2016 Nov; 13():80-89. PubMed ID: 27840009
[TBL] [Abstract][Full Text] [Related]
19. Combining MRI and Histologic Imaging Features for Predicting Overall Survival in Patients with Glioma.
Rathore S; Chaddad A; Iftikhar MA; Bilello M; Abdulkadir A
Radiol Imaging Cancer; 2021 Jul; 3(4):e200108. PubMed ID: 34296969
[TBL] [Abstract][Full Text] [Related]
20. Prediction of lower-grade glioma molecular subtypes using deep learning.
Matsui Y; Maruyama T; Nitta M; Saito T; Tsuzuki S; Tamura M; Kusuda K; Fukuya Y; Asano H; Kawamata T; Masamune K; Muragaki Y
J Neurooncol; 2020 Jan; 146(2):321-327. PubMed ID: 31865510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
